Form 8-K - Current report:
SEC Accession No. 0001079973-25-000102
Filing Date
2025-01-17
Accepted
2025-01-17 17:05:08
Documents
16
Period of Report
2025-01-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 26412
2 PRESS RELASE ex99x1.htm EX-99.1 3152
3 GRAPHIC image_001.jpg GRAPHIC 10182
  Complete submission text file 0001079973-25-000102.txt   260781

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE scpx-20250117.xsd EX-101.SCH 3549
5 XBRL DEFINITION FILE scpx-20250117_def.xml EX-101.DEF 26579
6 XBRL LABEL FILE scpx-20250117_lab.xml EX-101.LAB 36527
7 XBRL PRESENTATION FILE scpx-20250117_pre.xml EX-101.PRE 25203
18 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5514
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 25539485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)